Hospital Pharmacists' Awareness and Perspective Toward the Management of COVID-19 Pandemic in the Kingdom of Saudi Arabia

Overview

Journal Pharm Pract (Granada)

Date 2023 Feb 3

PMID 36733526

Authors

Dalal Salem Al-Dossari

Ibrahim Abdulaziz Al-Zaagi

Reem Faisal Bamogaddam

Rashid Hamoud Alnajrani

Nouf Rashid Alnajrani

Hamdan Najib Alajami

Raghad Abdullah AlOtaibi

Khulood Salim AlShammary

Anfal Jamal AlOtaibi

Anum Yousaf

Sheraz Ali

Affiliations

Soon will be listed here.

Abstract

Objectives: This study investigates the hospital pharmacists' awareness of important facts about the COVID-19 disease and their source of information, as well as their perception.

Methods: This cross-sectional study using a self-administered questionnaire was conducted from November 2020 to March 2021 in the Kingdom of Saudi Arabia (KSA). The questionnaire was developed via electronic platform and invitations were sent to pharmacists working in private and government hospitals. A multivariate logistic regression was used to identify factors associated with awareness of COVID-19.

Results: A total of 272 pharmacists submitted their responses via weblink. Many pharmacists (n=228, 84%) followed the latest COVID-19 updates on treatment and updated their information mainly through World Health Organization documents (n=151, 56%). Pharmacists working in secondary and tertiary hospitals were relatively five-times times (AOR = 4.59; 95% CI: 1.69-12.8; p-value = 0.003) and three-times (AOR = 2.93; 95% CI: 1.35-6.72; p-value = 0.008) more aware of COVID-19 than those working in primary hospitals. Pharmacists with prior adequate knowledge regarding epidemics and pandemics were two-times more likely to have a good awareness of COVID-19 compared to those who had received none (AOR = 2.15; 95% CI: 1.09-4.35; p-value = 0.030).

Conclusions: Half of the pharmacists believed that they received required education in the past about epidemics and pandemics, and many follow the recent COVID-19 updates on medicines predominantly from the WHO followed by the government awareness campaigns. Many pharmacists believed they have a key role in the management of epidemics/pandemics via their hospital pharmacy. However, this study identified certain awareness gaps regarding COVID-19, highlighting areas of improvement.

References

Wahidiyat P, Yo E, Wildani M, Triatmono V, Yosia M . Cross-sectional study on knowledge, attitude and practice towards thalassaemia among Indonesian youth. BMJ Open. 2021; 11(12):e054736. PMC: 8647533. DOI: 10.1136/bmjopen-2021-054736. View

AlRuthia Y, Alsenaidy M, Alrabiah H, AlMuhaisen A, Alshehri M . The status of licensed pharmacy workforce in Saudi Arabia: a 2030 economic vision perspective. Hum Resour Health. 2018; 16(1):28. PMC: 6022294. DOI: 10.1186/s12960-018-0294-8. View

Basheti I, El-Hajji F, Nassar R, Thiab S, Barakat M, Basheti M . Pharmacists' awareness of COVID-19 and perceptions of their roles, barriers, and roles of policymakers: Exploring the Middle East and North Africa (MENA). Int J Clin Pract. 2021; 75(6):e14074. PMC: 7995131. DOI: 10.1111/ijcp.14074. View

Ahmad A, Alkharfy K, Alrabiah Z, Alhossan A . Saudi Arabia, pharmacists and COVID-19 pandemic. J Pharm Policy Pract. 2020; 13:41. PMC: 7351647. DOI: 10.1186/s40545-020-00243-1. View

Karasneh R, Al-Azzam S, Muflih S, Soudah O, Hawamdeh S, Khader Y . Media's effect on shaping knowledge, awareness risk perceptions and communication practices of pandemic COVID-19 among pharmacists. Res Social Adm Pharm. 2020; 17(1):1897-1902. PMC: 7179508. DOI: 10.1016/j.sapharm.2020.04.027. View

Silva B, Fegadolli C . Implementation of pharmaceutical care for older adults in the brazilian public health system: a case study and realistic evaluation. BMC Health Serv Res. 2020; 20(1):37. PMC: 6958615. DOI: 10.1186/s12913-020-4898-z. View

Hussain R, Dawoud D, Babar Z . Drive-thru pharmacy services: A way forward to combat COVID-19 pandemic. Res Social Adm Pharm. 2020; 17(1):1920-1924. PMC: 7373674. DOI: 10.1016/j.sapharm.2020.07.015. View

Li H, Zheng S, Liu F, Liu W, Zhao R . Fighting against COVID-19: Innovative strategies for clinical pharmacists. Res Social Adm Pharm. 2020; 17(1):1813-1818. PMC: 7194937. DOI: 10.1016/j.sapharm.2020.04.003. View

Al-Quteimat MSc BCOP O, Amer R.Ph MSc A . SARS-CoV-2 outbreak: How can pharmacists help?. Res Social Adm Pharm. 2020; 17(2):480-482. PMC: 7271257. DOI: 10.1016/j.sapharm.2020.03.018. View

10.

Sanders J, Monogue M, Jodlowski T, Cutrell J . Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020; 323(18):1824-1836. DOI: 10.1001/jama.2020.6019. View

11.

Ung C . Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak. Res Social Adm Pharm. 2020; 16(4):583-586. PMC: 7129623. DOI: 10.1016/j.sapharm.2020.02.003. View

12.

Basheti I, Mhaidat N, Al-Azzam S, Alqudah R, Nassar R, Alzubaidi H . Knowledge and perceptions of pharmacists' readiness during coronavirus pandemic: the case of United Arab Emirates. J Pharm Policy Pract. 2021; 14(1):102. PMC: 8637029. DOI: 10.1186/s40545-021-00382-z. View

13.

Meo S, Alhowikan A, Al-Khlaiwi T, Meo I, Halepoto D, Iqbal M . Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. Eur Rev Med Pharmacol Sci. 2020; 24(4):2012-2019. DOI: 10.26355/eurrev_202002_20379. View

14.

Meo S, Al-Khlaiwi T, Usmani A, Meo A, Klonoff D, Hoang T . Biological and epidemiological trends in the prevalence and mortality due to outbreaks of novel coronavirus COVID-19. J King Saud Univ Sci. 2020; 32(4):2495-2499. PMC: 7144605. DOI: 10.1016/j.jksus.2020.04.004. View

15.

Capuano A, Scavone C, Racagni G, Scaglione F . NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?. Pharmacol Res. 2020; 157:104849. PMC: 7189871. DOI: 10.1016/j.phrs.2020.104849. View

16.

Manolakis P, Skelton J . Pharmacists' contributions to primary care in the United States collaborating to address unmet patient care needs: the emerging role for pharmacists to address the shortage of primary care providers. Am J Pharm Educ. 2011; 74(10):S7. PMC: 3058447. DOI: 10.5688/aj7410s7. View

17.

Diri R . The Impact of COVID-19 Outbreak on Reassessing the Need for Drive Thru Community Pharmacy: Cross-Sectional Study. J Microsc Ultrastruct. 2021; 8(4):162-164. PMC: 7883499. DOI: 10.4103/JMAU.JMAU_65_20. View

18.

Basheti I, Nassar R, Barakat M, Alqudah R, AbuFarha R, Mukattash T . Pharmacists' readiness to deal with the coronavirus pandemic: Assessing awareness and perception of roles. Res Social Adm Pharm. 2020; 17(3):514-522. PMC: 7194707. DOI: 10.1016/j.sapharm.2020.04.020. View

19.

Khan Z, Muhammad K, Ahmed A, Rahman H . Coronavirus outbreaks: prevention and management recommendations. Drugs Ther Perspect. 2020; 36(5):215-217. PMC: 7095077. DOI: 10.1007/s40267-020-00717-x. View